Cathepsins as effector proteases in hepatocyte apoptosis.
Roberts
L R
LR
Center for Basic Research in Digestive Diseases, Mayo Clinic, Rochester, MN 55905, USA.
Adjei
P N
PN
Gores
G J
GJ
D000818:Animals; D017209:Apoptosis; D001647:Bile Acids and Salts / Q000494:pharmacology; D002166:Camptothecin / Q000494:pharmacology; D002401:Cathepsin B / Q000502:physiology*; D002402:Cathepsin D / Q000502:physiology*; D002478:Cells, Cultured; D016373:DNA, Antisense / Q000378:metabolism; D010450:Endopeptidases / Q000502:physiology*; D008099:Liver / Q000378:metabolism*; D008954:Models, Biological; D010436:Pepstatins / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats
D001647:Bile Acids and Salts; D016373:DNA, Antisense; D010436:Pepstatins; D011480:Protease Inhibitors; C014195:Streptomyces pepsin inhibitor; D010450:Endopeptidases; D002401:Cathepsin B; D002402:Cathepsin D; C031375:pepstatin; D002166:Camptothecin